Lyka Labs reports Kunal Gandhi’s open‑market purchase of 14,176 shares, raising his stake to 9.85%
The promoter Kunal Gandhi and his concert parties bought 14,176 equity shares on 29 June 2026, increasing his voting‑shareholding to 9.85% of Lyka Labs.
What Lyka Labs announced
Lyka Labs Limited (BSE: 500259, NSE: LYKALABS) disclosed that promoter Kunal N. Gandhi, together with persons acting in concert (PACs), acquired additional equity shares on 29 June 2026. The acquisition was executed through the open market and was reported to the stock exchanges under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
"The acquisition increased Mr. Gandhi’s voting‑shareholding to 9.85% of the total diluted share capital of Lyka Labs."
The filing, submitted on 30 June 2026, details the pre‑ and post‑acquisition shareholdings of the acquirer and the PACs, the mode of acquisition, and the unchanged total equity share capital of the company.
Details of the acquisition
- Acquirer: Mr. Kunal N. Gandhi (promoter)\
- Persons Acting in Concert: Mrs. Nehal N. Gandhi, Mrs. Alisha K. Gandhi, Enai Trading and Investment Private Limited, Lyka Generics Limited, Hiralaxmi Multitrade Pvt Ltd\
- Mode of acquisition: Open market purchase\
- Date of acquisition: 29 June 2026\
- Number of shares acquired: 14,176 equity shares carrying voting rights\
- Percentage of total diluted voting capital acquired: 0.04%\
- Total equity share capital of Lyka Labs: 3,56,90,000 shares (unchanged before and after the transaction).
The filing shows that prior to the purchase, Mr. Gandhi held 35,00,162 shares (9.81% of diluted voting capital). After acquiring the additional 14,176 shares, his holding rose to 35,14,338 shares, representing 9.85% of the diluted voting capital.
Shareholding pattern before and after the transaction
| Shareholder | Shares before | % of diluted capital before | Shares after | % of diluted capital after |
|---|---|---|---|---|
| Kunal N. Gandhi | 35,00,162 | 9.81% | 35,14,338 | 9.85% |
| Nehal N. Gandhi | 11,95,493 | 3.35% | 11,95,493 | 3.35% |
| Alisha K. Gandhi | 50,000 | 0.14% | 50,000 | 0.14% |
| Enai Trading & Investment Pvt Ltd | 10,11,312 | 2.83% | 10,11,312 | 2.83% |
| Lyka Generics Ltd | 20,000 | 0.06% | 20,000 | 0.06% |
| Hiralaxmi Multitrade Pvt Ltd | 708 | 0.00% | 708 | 0.00% |
| Total (acquirer + PACs) | 57,77,675 | 16.19% | 57,91,851 | 16.23% |
The total voting‑shareholding of the promoter group therefore increased marginally from 16.19% to 16.23% of the company’s diluted share capital.
Key facts at a glance
| Detail | Value |
|---|---|
| Company | Lyka Labs Ltd |
| BSE Scrip Code | 500259 |
| NSE Symbol | LYKALABS |
| Filing date | 30 June 2026 |
| Regulation invoked | SEBI (SAST) Reg. 29(2) |
| Acquirer | Kunal N. Gandhi (promoter) |
| PACs | Mrs. Nehal N. Gandhi, Mrs. Alisha K. Gandhi, Enai Trading & Investment Pvt Ltd, Lyka Generics Ltd, Hiralaxmi Multitrade Pvt Ltd |
| Shares acquired | 14,176 equity shares (0.04% of diluted capital) |
| Post‑acquisition stake of Kunal Gandhi | 9.85% of diluted voting capital |
| Total equity share capital | 3,56,90,000 shares |
| Mode of acquisition | Open market |
Why this matters for investors
The filing confirms that the promoter group has modestly increased its voting influence in Lyka Labs. Because the total equity share capital remains unchanged, the transaction does not dilute existing shareholders; instead, it slightly consolidates promoter control. Under SEBI’s takeover regulations, any acquisition that pushes a promoter’s holding above 25% would trigger additional disclosure and possibly a mandatory open offer, but the current level of 9.85% remains well below that threshold. Investors can therefore note that the promoter’s confidence, as expressed through the purchase, is limited in scale and does not materially alter the company’s capital structure.
Conclusion
Lyka Labs disclosed that promoter Kunal Gandhi purchased 14,176 open‑market shares on 29 June 2026, raising his individual voting stake to 9.85% and the combined promoter group’s holding to 16.23% of the diluted share capital. The transaction was reported under SEBI Regulation 29(2) and does not affect the company’s total equity share count. No further approvals or actions are required at this stage, and the filing provides a transparent view of the promoter’s incremental stake.
Frequently asked questions
Related stocks
Source filing: view original